FindMyKOL
Clinical trialNCT02951234UnknownInterventional

A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease

NCT02951234 is an interventional trial sponsored by Chang Gung Memorial Hospital. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Kawasaki Disease. The registry lists an enrollment of 278 participants at 5 sites in 1 country. The registry lists a start date of 30 Sept 2016 and a primary completion date of 31 Aug 2019.

SponsorChang Gung Memorial Hospital →Enrollment278Kawasaki Disease
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02951234
FieldValue
Registry IDNCT02951234
StatusUnknown
Study typeInterventional trial
Lead sponsorChang Gung Memorial Hospital
Enrollment278
Registered sites5
Countries1
ConditionsKawasaki Disease
Start30 Sept 2016
Primary completion31 Aug 2019
Study completion31 Aug 2019
Last update posted6 Mar 2018

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Kawasaki disease (KD) is an acute febrile systemic vasculitis most commonly seen in children under the age of 5 years old. This trial has been designed as a multi-center, prospective, randomized controlled, evaluator-blinded trial with two parallel groups to determine whether IVIG alone as the primary therapy in acute-stage KD is as effective as IVIG combined with high-dose aspirin therapy. The primary endpoint is defined as CAL formation at 6-8 weeks.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Ho-Chang Kuo, MD, PhD

    Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan5 sites, 5 recruiting
  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City

    Recruiting
  • Kaohsiung Veterans General Hospital

    Kaohsiung City

    Recruiting
  • Taichung Veterans General Hospital

    Taichung

    Recruiting
  • Tungs' Taichung Metroharbor Hospital

    Taichung

    Recruiting
  • Linkou Chang Gung Memorial Hospital

    Taipei

    Recruiting

Sites by country

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02951234

Each answer restates registry values shown on this page.

What is NCT02951234?

NCT02951234 is an interventional trial sponsored by Chang Gung Memorial Hospital. It studies Kawasaki Disease.

Who leads NCT02951234?

The registry names Ho-Chang Kuo, MD, PhD (principal investigator, Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital) as the overall official.

Where does NCT02951234 run?

The registry lists 5 sites in 1 country. Every site with a stated country is in one country: Taiwan.

When is NCT02951234 expected to complete?

The registry lists a primary completion date of 31 Aug 2019 and a study completion date of 31 Aug 2019. The sponsor last updated the record on 6 Mar 2018.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.